Brain natriuretic peptide in diagnosis and therapy of congestive heart failure

被引:0
|
作者
Redfield, MM
Block, PC
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Determining the cause of acute dyspnea in the emergency department (ED) is a frequent diagnostic challenge. The two most common causes of acute dyspnea are congestive heart failure (CHF) and pulmonary disease, conditions that can be difficult. to tell apart clinically. A correct diagnosis is usually based on physical examination, laboratory tests, and chest x-rays, all of which can yield nonspecific findings.(1) Brain natriuretic peptide (BNP) is a cardiac hormone with vasodilating, natriuretic, lusitropic, and renin-angiotensin-aldosterone inhibiting properties. BNP is secreted primarily by the myocardium in response to volume expansion and pressure overload. BNP and atrial natriuretic peptide (ANP) are activated by ventricular and atrial distension due to increased intracardiac pressure.
引用
收藏
页码:CS1 / +
页数:4
相关论文
共 50 条
  • [1] Brain natriuretic peptide in the diagnosis and management of congestive heart failure
    Trinity, E
    Apple, FS
    [J]. LABORATORY MEDICINE, 2002, 33 (10) : 793 - 796
  • [2] Value of brain natriuretic peptide in the diagnosis and treatment of congestive heart failure
    Cheng, TO
    [J]. CARDIOLOGY, 2000, 94 (02) : 129 - 129
  • [3] Brain natriuretic peptide, clinical reasoning, and congestive heart failure
    Ammar, Hussam
    Malani, Ashok Kumar
    Gupta, Chakshu
    Dohyan, Dennis C.
    [J]. AMERICAN JOURNAL OF CRITICAL CARE, 2006, 15 (06) : 614 - 616
  • [4] Brain natriuretic peptide in the contemporary management of congestive heart failure
    Wasywich, Cara A.
    Whalley, Gillian A.
    Doughty, Robert N.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (01) : 71 - 84
  • [5] Brain natriuretic peptide response is heterogeneous during β-blocker therapy for congestive heart failure
    Yoshizawa, A
    Yoshikawa, T
    Nakamura, I
    Satoh, T
    Moritani, K
    Suzuki, M
    Baba, A
    Iwanaga, S
    Mitamura, H
    Ogawa, S
    [J]. JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : 310 - 315
  • [6] Brain type natriuretic peptide (BNP) - A marker of new millennium in diagnosis of congestive heart failure
    Raizada A.
    Bhandari S.
    Khan M.A.
    Singh H.V.
    Thomas S.
    Sarabhai V.
    Singh N.
    Trehan N.
    [J]. Indian Journal of Clinical Biochemistry, 2007, 22 (1) : 4 - 9
  • [7] Brain natriuretic peptide - the biological marker in the diagnosis of overt congestive heart failure and myocardial ischemia
    Lisy, M.
    Babal, P.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (4-5): : 170 - 173
  • [8] Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure
    MacDonald, KA
    Kittleson, MD
    Munro, C
    Kass, P
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2003, 17 (02) : 172 - 177
  • [9] Nesiritide - A brain natriuretic peptide for acutely decompensated congestive heart failure
    Caron, MF
    White, CM
    [J]. FORMULARY, 2001, 36 (09) : 639 - 643
  • [10] INCREASED HUMAN BRAIN NATRIURETIC PEPTIDE IN CONGESTIVE HEART-FAILURE
    MUKOYAMA, M
    NAKAO, K
    SAITO, Y
    OGAWA, Y
    HOSODA, K
    SUGA, SI
    SHIRAKAMI, G
    JOUGASAKI, M
    IMURA, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (11): : 757 - 758